152 related articles for article (PubMed ID: 3480081)
21. Differences in the intracellular pharmacokinetics of cytosine arabinoside (AraC) between circulating leukemic blasts and normal mononuclear blood cells.
Hiddemann W; Schleyer E; Unterhalt M; Zühlsdorf M; Rolf C; Reuter C; Kewer U; Uhrmeister C; Wörmann B; Büchner T
Leukemia; 1992 Dec; 6(12):1273-80. PubMed ID: 1453772
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
Cashen AF; Shah AK; Todt L; Fisher N; DiPersio J
Cancer Chemother Pharmacol; 2008 Apr; 61(5):759-66. PubMed ID: 17564707
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia.
Kearns CM; Blakley RL; Santana VM; Crom WR
Cancer Res; 1994 Mar; 54(5):1235-9. PubMed ID: 7906999
[TBL] [Abstract][Full Text] [Related]
24. Dosing of thioTEPA for myeloablative therapy.
Przepiorka D; Madden T; Ippoliti C; Estrov Z; Dimopoulos M
Cancer Chemother Pharmacol; 1995; 37(1-2):155-60. PubMed ID: 7497586
[TBL] [Abstract][Full Text] [Related]
25. Effect of very high-dose thymidine infusions on leukemia and lymphoma patients.
Blumenreich MS; Woodcock TM; Andreeff M; Hiddemann W; Chou TC; Vale K; O'Hehir M; Clarkson BD; Young CW
Cancer Res; 1984 May; 44(5):2203-7. PubMed ID: 6713407
[TBL] [Abstract][Full Text] [Related]
26. In vivo and in vitro sensitization of leukemic cells to adriamycin-induced apoptosis by pentoxifylline. Involvement of caspase cascades and IkappaBalpha phosphorylation.
Lerma-Díaz JM; Hernández-Flores G; Domínguez-Rodríguez JR; Ortíz-Lazareno PC; Gómez-Contreras P; Cervantes-Munguía R; Scott-Algara D; Aguilar-Lemarroy A; Jave-Suárez LF; Bravo-Cuellar A
Immunol Lett; 2006 Mar; 103(2):149-58. PubMed ID: 16388856
[TBL] [Abstract][Full Text] [Related]
27. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
Early AP; Preisler HD; Slocum H; Rustum YM
Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
[TBL] [Abstract][Full Text] [Related]
28. [Targeting delivery of liposomal adriamycin by intra-lymphatic infusion].
Feng B; Lang J; Li D
Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):156-8. PubMed ID: 9596890
[TBL] [Abstract][Full Text] [Related]
29. Intratumoural injection of calcium channel blocker enhances cytotoxicity of adriamycin in Ehrlich ascites solid tumour.
Matsuoka H; Sugimachi K; Kuwano H; Yano K
Eur J Surg Oncol; 1989 Jun; 15(3):224-31. PubMed ID: 2737309
[TBL] [Abstract][Full Text] [Related]
30. In vivo and in vitro pharmacokinetic differences between four structurally closely related anthracyclines in hematopoietic cell subtypes in humans.
Speth PA; Linssen PC; Termond EF; Boezeman JB; Wessels HM; Haanen C
Drug Metab Dispos; 1989; 17(1):98-105. PubMed ID: 2566478
[TBL] [Abstract][Full Text] [Related]
31. Clinical pharmacokinetic study of tiazofurin administered as a 1-hour infusion.
Jayaram HN; Lapis E; Tricot G; Kneebone P; Paulik E; Zhen W; Engeler GP; Hoffman R; Weber G
Int J Cancer; 1992 May; 51(2):182-8. PubMed ID: 1568787
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to uranyl nitrate-induced acute renal failure rats.
Lee HJ; Paik WH; Lee MG
Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):195-204. PubMed ID: 8832911
[TBL] [Abstract][Full Text] [Related]
33. [Effects of itraconazole plus doxorubicin on proliferation and apoptosis in acute myeloid leukemia cells].
Wang J; Xu X; Zhou R; Guo K
Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(4):299-305. PubMed ID: 25877249
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones.
Tsuruo T; Iida-Saito H; Kawabata H; Oh-hara T; Hamada H; Utakoji T
Jpn J Cancer Res; 1986 Jul; 77(7):682-92. PubMed ID: 3091555
[TBL] [Abstract][Full Text] [Related]
35. 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate pharmacokinetics in plasma and tumor cells of patients with relapsed leukemia and lymphoma.
Danhauser L; Plunkett W; Keating M; Cabanillas F
Cancer Chemother Pharmacol; 1986; 18(2):145-52. PubMed ID: 2431803
[TBL] [Abstract][Full Text] [Related]
36. Multidrug resistance in cultured human leukemia and lymphoma cell lines detected by a monoclonal antibody, MRK16.
Ishida Y; Ohtsu T; Hamada H; Sugimoto Y; Tobinai K; Minato K; Tsuruo T; Shimoyama M
Jpn J Cancer Res; 1989 Oct; 80(10):1006-13. PubMed ID: 2575608
[TBL] [Abstract][Full Text] [Related]
37. Intermediate-dose cytarabine treatment delivered at moderate infusion rates for de novo acute myeloid leukemia-results of a phase I-II study.
Mantovani L; Hasenclever D; Krahl R; Pönisch W; Herold M; Pasold R; Fiedler F; Dölken G; Kämpfe D; Schmoll HJ; Súbert R; Kubel M; Niederwieser D; Helbig W;
Leuk Lymphoma; 2002 Feb; 43(2):265-74. PubMed ID: 11999557
[TBL] [Abstract][Full Text] [Related]
38. A phase I study of idarubicin hydrochloride in patients with acute leukemia. The Idarubicin Study Group of Japan.
Tamura K
Semin Hematol; 1996 Oct; 33(4 Suppl 3):2-11. PubMed ID: 8916310
[TBL] [Abstract][Full Text] [Related]
39. High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study.
Tedeschi A; Montillo M; Strocchi E; Cafro AM; Tresoldi E; Intropido L; Nichelatti M; Marbello L; Baratè C; Camaggi CM; Morra E
Cancer Chemother Pharmacol; 2007 May; 59(6):771-9. PubMed ID: 17256136
[TBL] [Abstract][Full Text] [Related]
40. Phase I clinical investigation of benzisoquinolinedione (amonafide) in adults with refractory or relapsed acute leukemia.
O'Brien S; Benvenuto JA; Estey E; Beran M; Felder TB; Keating M
Cancer Res; 1991 Feb; 51(3):935-8. PubMed ID: 1988134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
